We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
AUM
$1.3B
AUM Growth
-$664M
Cap. Flow
-$748M
Cap. Flow %
-57.34%
Top 10 Hldgs %
32.39%
Holding
84
New
4
Increased
6
Reduced
47
Closed
8

Top Buys

Rank Stock Value
1
PNR icon
Pentair
PNR
+$20.3M
2
NATI
National Instruments Corp
NATI
+$17.7M
3
GLW icon
Corning
GLW
+$16.6M
4
CVSA
Covista Inc
CVSA
+$9.5M
5
QGEN icon
Qiagen
QGEN
+$9.09M

Sector Composition

Rank Sector Weight
1 Technology 17.83%
2 Industrials 16.75%
3 Consumer Discretionary 14.95%
4 Communication Services 12.64%
5 Consumer Staples 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAR icon
51
Clarus
CLAR
$125M
$1.5M 0.12%
111,337
AIOT
52
PowerFleet Inc
AIOT
$537M
$1.3M 0.1%
199,488
HYPD
53
Hyperion DeFi Inc
HYPD
$35.5M
$1.01M 0.08%
2,807
GILD icon
54
Gilead Sciences
GILD
$165B
$975K 0.07%
15,000
BC icon
55
Brunswick
BC
$5.23B
$900K 0.07%
15,000
SANW
56
DELISTED
S&W Seed Co
SANW
$855K 0.07%
21,424
FLL icon
57
Full House Resorts
FLL
$83.4M
$748K 0.06%
223,232
AUD
58
DELISTED
Audacy, Inc.
AUD
$747K 0.06%
160,895
LIND icon
59
Lindblad Expeditions
LIND
$1.95B
$735K 0.06%
44,924
OVID icon
60
Ovid Therapeutics
OVID
$427M
$588K 0.05%
141,700
+40,700
+40% +$129K
BMY icon
61
Bristol-Myers Squibb
BMY
$129B
$587K 0.05%
9,140
-1,850
-17% -$106K
LBY
62
DELISTED
Libbey, Inc.
LBY
$566K 0.04%
390,068
-71,125
-15% -$133K
QCOM icon
63
Qualcomm
QCOM
$164B
$511K 0.04%
5,790
-1,100
-16% -$92K
MBII
64
DELISTED
Marrone Bio Innovations, Inc.
MBII
$470K 0.04%
465,400
+50,000
+12% +$60.6K
WAT icon
65
Waters Corp
WAT
$37.3B
$374K 0.03%
1,600
-375
-19% -$82.8K
CMC icon
66
Commercial Metals
CMC
$7.53B
$345K 0.03%
15,500
CSCO icon
67
Cisco
CSCO
$443B
$329K 0.03%
+6,850
New +$318K
IBM icon
68
IBM
IBM
$213B
$295K 0.02%
2,301
-366
-14% -$47.6K
ABTC
69
American Bitcoin Corp
ABTC
$379M
$295K 0.02%
+1
New +$212K
RMD icon
70
ResMed
RMD
$31.1B
$280K 0.02%
1,810
-100
-5% -$14.4K
JPM.PRG
71
DELISTED
JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non
JPM.PRG
$258K 0.02%
10,000
GE icon
72
GE Aerospace
GE
$364B
$150K 0.01%
2,689
-5,999
-69% -$310K
XCUR icon
73
Exicure
XCUR
$11M
$109K 0.01%
253
KIN
74
DELISTED
Kindred Biosciences, Inc.
KIN
$85K 0.01%
10,000
GNTX icon
75
Gentex
GNTX
$5.1B
-476,285
Closed -$13.1M

Similar funds

Fairpointe Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Fairpointe Capital held 84 positions worth $1.3B, down 34% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Fairpointe Capital withdrew a net $748M in Q4 2019, closing 8 positions and reducing 47 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Fairpointe Capital opened a new position in National Instruments Corp worth $17.9M.

  • Fairpointe Capital's largest Q4 2019 buy was National Instruments Corp: 423,517 shares worth $17.9M.
  • Fairpointe Capital added most to Pentair in Q4 2019, an estimated $20.3M increase.
  • Fairpointe Capital's biggest Q4 2019 reduction was LKQ Corp, cutting an estimated $36.9M.
  • Fairpointe Capital fully exited Nuance Communications, Inc. in Q4 2019, selling an estimated $28.2M.
  • Fairpointe Capital's ten largest holdings make up 32% of its $1.3B portfolio in Q4 2019.
  • Fairpointe Capital opened 4 new positions and closed 8 in Q4 2019.
  • Fairpointe Capital's portfolio value fell 34% quarter-over-quarter to $1.3B.

Based on Fairpointe Capital's 13F filing for Q4 2019, filed 14 Feb 2020.